课题基金 / 基金详情

Anti-parathyroid hormone-related protein (PTHrP) monoclonal antibodies against metastatic cancer

Anti-parathyroid hormone-related protein (PTHrP) monoclonal antibodies against metastatic cancer
抗转移性癌症的抗甲状旁腺激素相关蛋白 (PTHrP) 单克隆抗体
批准号：
470394
负责人：
Kremer Richard B
金额：
$48.49万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2025-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=470394&lang=en
关键词：
Biomarkers Cancer Targeted Therapy Humanized Monoclonal Antibodies Ind Enabling Studies Parathyroid Hormone-Related Protein

项目摘要

项目成果

Kremer Richard B的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer is the leading cause of death in the developed world; the Canadian Cancer Society estimates that there will be 233,900 new cases and 85,100 deaths from cancer in Canada in 2022. Frighteningly, 1 out of 4 Canadians will die of the disease. Most canc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Co-targeting parathyroid hormone-related protein (PTHrP) and osteoclast activation to counter breast cancer metastasis to bone.
Effect of 1,25 dihydroxyvitamin D on control of cell growth and differentiation
Co-targeting parathyroid-hormone related protein (PTHrP) signaling and osteoclast activation to counter breast cancer metastasis to bone
  • 批准号：
    321112
  • 项目类别：
    Operating Grants
  • 资助金额：
    $53.91万
  • 财政年份：
    2015
  • 负责人：
    Kremer Richard B
  • 依托单位：
    McGill University
Effect of 1,25 dihydroxyvitamin D on control of cell growth and differentiation
  • 批准号：
    280255
  • 项目类别：
    Operating Grants
  • 资助金额：
    $50.07万
  • 财政年份：
    2013
  • 负责人：
    Kremer Richard B
  • 依托单位：
    McGill University
海外基金